DePuy Synthes’ OUS Challenges Bring Second Quarter Declines

DePuy Synthes reported 2Q22 orthopedic sales of $2,156.3 million, -3.1% vs. 2Q21. For the first half of 2022, the company generated $4,343.3 million, +0.1% compared to the year prior.

The company faced a steep comparison going against 2Q21, its second-highest total revenue quarter in the last three and a half years. COVID restrictions,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us